Literature DB >> 14903507

Hydrazine derivatives of isonicotinic acid (rimifon marsilid) in the treatment of active progressive caseous-pneumonic tuberculosis; a preliminary report.

E H ROBITZEK, I J SELIKOFF.   

Abstract

Entities:  

Keywords:  NICOTINIC ACID/derivatives; TUBERCULOSIS, PULMONARY/therapy

Mesh:

Substances:

Year:  1952        PMID: 14903507     DOI: 10.1164/art.1952.65.4.402

Source DB:  PubMed          Journal:  Am Rev Tuberc        ISSN: 0096-0381


× No keyword cloud information.
  24 in total

1.  [EEG CHANGES IN A PSYCHOSIS CAUSED BY INH AND AFTER A SUICIDE ATTEMPT WITH NICOTEBEN].

Authors:  S KUBICKI; K IBE; W GOETZE
Journal:  Arch Toxikol       Date:  1964-05-27

2.  An assessment of antibacterial treatment used alone or in association with surgical operation in the treatment of pulmonary tuberculosis.

Authors:  J R EDGE; W H HELM; M R GEAKE; R L WARD
Journal:  Thorax       Date:  1961-09       Impact factor: 9.139

3.  Use of iproniazid in ischaemic angina pectoris.

Authors:  M K TOWERS; P WOOD
Journal:  Br Med J       Date:  1958-11-01

4.  Preliminary observations on cavodil in treatment of angina pectoris.

Authors:  J MACKINNON; D E ANDERSON; G HOWITT
Journal:  Br Med J       Date:  1960-01-23

5.  The comparative pharmacology of some psychotropic drugs.

Authors:  E JACOBSEN
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

6.  Studies in experimental ocular tuberculosis. XVII. The effect of isoniazid in the normal, nonimmune rabbit.

Authors:  A C WOODS; B BECKER; R M WOOD
Journal:  Trans Am Ophthalmol Soc       Date:  1953

7.  A comparison of isoniazid with modified insulin therapy in neurotic states.

Authors:  M SILVERMAN
Journal:  J Neurol Neurosurg Psychiatry       Date:  1954-05       Impact factor: 10.154

8.  Isonicotinic acid hydrazide in pulmonary tuberculosis.

Authors:  A D LAPP; G A BLACK; J N O'RAFFERTY
Journal:  Can Med Assoc J       Date:  1952-12       Impact factor: 8.262

9.  Chemotherapy of pulmonary tuberculosis in young adults; an analysis of the combined results of three Medical Research Council trials.

Authors:  M DANIELS; A B HILL
Journal:  Br Med J       Date:  1952-05-31

10.  NADH dehydrogenase defects confer isoniazid resistance and conditional lethality in Mycobacterium smegmatis.

Authors:  L Miesel; T R Weisbrod; J A Marcinkeviciene; R Bittman; W R Jacobs
Journal:  J Bacteriol       Date:  1998-05       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.